Currently, there are 764.15M common shares owned by the public and among those 748.87M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -3.32% and -0.79% over the past three months. CTRA shares are trading 3.64% year to date (YTD), with the 12-month market performance up to 2.68% higher. It has a 12-month low price of $22.30 and touched a high of $29.95 over the same period. CTRA has an average intraday trading volume of 6.27 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.18%, -2.90%, and 2.50% respectively.
Institutional ownership of Coterra Energy Inc (NYSE: CTRA) shares accounts for 90.65% of the company’s 764.15M shares outstanding.
It has a market capitalization of $20.23B and a beta (3y monthly) value of 0.52. The stock’s trailing 12-month PE ratio is 17.63, while the earnings-per-share (ttm) stands at $1.50. The company has a PEG of 0.54 and a Quick Ratio of 2.88 with the debt-to-equity ratio at 0.29. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.05% over the week and 3.01% over the month.
Earnings per share for the fiscal year are expected to increase by 86.30%, and 15.69% over the next financial year. EPS should grow at an annualized rate of 32.65% over the next five years, compared to -1.62% over the past 5-year period.
Looking at the support for the CTRA, a number of firms have released research notes about the stock. ROTH MKM stated their Buy rating for the stock in a research note on August 27, 2024, with the firm’s price target at $25-$29. Wolfe Research coverage for the Coterra Energy Inc (CTRA) stock in a research note released on July 18, 2024 offered a Outperform rating with a price target of $35. BofA Securities was of a view on June 14, 2024 that the stock is Buy, while Truist gave the stock Buy rating on May 16, 2024, issuing a price target of $27- $35. Barclays on their part issued Overweight rating on April 10, 2024.
